Key points are not available for this paper at this time.
In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection. The unexpectedly high rejection rates are of serious concern and indicate the need for better immunotherapy. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00074386.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter G. Stock
Burc Barin
Barbara Murphy
Scripps Research Institute
New England Journal of Medicine
Johns Hopkins University
University of Chicago
University of California, San Francisco
Building similarity graph...
Analyzing shared references across papers
Loading...
Stock et al. (Wed,) studied this question.
synapsesocial.com/papers/69de779957c7c8340a55885a — DOI: https://doi.org/10.1056/nejmoa1001197